A Week of Promise for Access to Medicines

by ALEX LAWRENCE, Communications Advisor

At the 71st World Health Assembly, the great and the good (and sometimes, not so good) of global health came together on some of the most pressing health challenges we face.

On the agenda, and of particular interest to Health Action International (HAI), were the World Health Organization’s (WHO) General Programme of Work (GPW13),

What Role Can Civil Society Play in the European Regulatory Process?

by ANCEL.LA SANTOS, Senior Policy Advisor

The formal engagement of patients and consumers in the pharmaceutical regulatory process helps ensure that important decisions about medicines take into account the thoughts and views of the people they most affect. The European Medicines Agency (EMA) has a long tradition of this kind of stakeholder involvement.

On the Road in Kilifi County: HAI Launches Snakebite Programme in Kenya

by BEN WALDMANN, Snakebite Project Manager and SOPHIE VON BERNUS, Project Associate Health Action International’s (HAI) snakebite team temporarily traded the grey skies of Amsterdam for the sunny coasts of East Africa. Communities living near the picturesque shorelines surrounding Mombasa, Kenya, are well acquainted with the risk of snakebite. Snakebite envenoming is a global health [...]

Open Science for Health: Shaping the New Framework Programme

by JAUME VIDAL, Policy Advisor - Europe Health Action International (HAI) and Commons Network were joined last week in a packed room at the European Parliament by European Union lawmakers, policy-makers and other civil society groups to debate the challenges and opportunities ahead for the medical research and development (R&D) system. Open Science for Health [...]

EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

by JAUME VIDAL, Policy Advisor – Europe

The European Union (EU) and Mercosur have been negotiating a free trade agreement for the last 16 years, with talks picking up pace in the last 15 months. Negotiations are now nearing completion and there are increasing concerns among public health advocates, patient and consumer organisations,

Facing a Global Threat – Roadmap to Combat Antimicrobial Resistance and the Bumps Along the Way

Interview with HELLE AARGAARD, Policy Advisor at ReAct – Action on Antibiotic Resistance

The Member State Consultation on the World Health Organization’s (WHO) proposed roadmap for the Global Development and Stewardship Framework to Combat Antimicrobial Resistance (AMR) was held on 9–10 November in Geneva. The first day was open for non-state actor participation.

New Dutch Government Must Ensure Transparency to Control Medicine Prices

by JAUME VIDAL After almost seven months of negotiations, The Netherlands has formed a new coalition government, which recently outlined its priorities and main policy objectives in its Coalition Agreement. On the whole, it’s good news from an access to medicines perspective—particularly pricing and procurement, which remain high on the government’s priority list. Some of [...]

Staff Spotlight: Tim Reed

A famous man, John Quincy Adams, once said, “If your actions inspire others to dream more, learn more, do more and become more, you are a leader”. Mr Adams was the sixth president of the United States of America—and the first to give an interview to a female journalist, Anne Royall, which was quite progressive for his time.

START TYPING AND PRESS ENTER TO SEARCH